WGU D236 Pathophysiology Objective Assessment Final
Practice Test | 2026/2027 Edition | 250 Verified Questions
WGU D236 Pathophysiology Final Exam Review 2026-2027 QUESTIONS AND ANSWERS
ALREADY GRADED A+. 100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive review guide contains 250 verified questions and correct answers designed to
prepare students for the WGU D236 Pathophysiology Objective Assessment. Covering key concepts in
cellular injury, inflammation, immune disorders, neoplasia, and systemic pathophysiology, this test
bank reflects the latest 2026/2027 curriculum. Each question includes detailed rationales to reinforce
understanding and ensure exam readiness. Ideal for final exam review, this resource helps students
achieve a passing score with confidence.
Key Features:
Cellular Adaptation, Injury, and Death
Inflammation and Tissue Repair
Immune System Disorders and Hypersensitivities
Neoplasia and Cancer Biology
Cardiovascular and Respiratory Pathophysiology
Renal, Endocrine, and Neurologic Disorders
Updates for 2026:
- Updated to reflect 2026/2027 WGU D236 course objectives
- Revised rationales for clarity and accuracy
- Added new questions on COVID-19 and emerging pathogens
- Enhanced distractor explanations to address common misconceptions
- Aligned with latest NCLEX-style question formats
Abstract:
The WGU D236 Pathophysiology Objective Assessment Final Practice Test is a rigorous compilation of 250
multiple-choice questions that mirror the content and difficulty of the actual exam. This test bank systematically
covers fundamental pathophysiological concepts including cellular injury mechanisms, inflammatory responses,
immune dysfunctions, neoplastic processes, and organ system pathologies. Each question is accompanied by a
correct answer and a detailed rationale that explains the underlying pathophysiology, distinguishes correct from
incorrect options, and reinforces key principles. The content is organized by body system and disease process,
allowing for targeted review. This resource is essential for nursing and healthcare students seeking to master
pathophysiology and excel in their final objective assessment. By engaging with these questions, learners will
develop critical thinking skills and a deep understanding of disease mechanisms, preparing them for clinical
practice and licensure examinations.
Keywords:
WGU D236, Pathophysiology, Objective Assessment, Final Exam Review, Test Bank, 250 Questions, NCLEX Prep,
Nursing Pathophysiology
Answer Format:
Each question is followed by the correct answer in bold, then a detailed rationale explaining why the answer is
correct and why the other options are incorrect. Rationales include pathophysiological mechanisms, clinical
correlations, and key distinctions to enhance understanding and retention.
Compliance Checklist:
All questions aligned with WGU D236 2026/2027 course objectives
Page 1
, Answers verified by subject matter experts
Rationales provided for every question
Questions formatted in NCLEX-style multiple choice
Content reviewed for accuracy and currency
Suitable for self-assessment and exam preparation
Content Area Overview:
Content Area Questions Key Topics Weight
Cellular Biology and Injury 1-40 Cell adaptation, injury, death, atrophy, 16%
hypertrophy, hyperplasia, metaplasia,
dysplasia, apoptosis, necrosis
Inflammation and Healing 41-70 Acute inflammation, chronic inflammation, 12%
chemical mediators, wound healing, repair,
regeneration
Immune System Disorders 71-100 Hypersensitivity reactions, autoimmune 12%
diseases, immunodeficiency, transplant
rejection, HIV/AIDS
Neoplasia 101-130 Carcinogenesis, tumor classification, 12%
metastasis, oncogenes, tumor suppressor
genes, cancer staging
Cardiovascular Pathophysiology 131-160 Atherosclerosis, hypertension, heart failure, 12%
myocardial infarction, valvular disorders,
arrhythmias
Respiratory Pathophysiology 161-185 COPD, asthma, pneumonia, pulmonary 10%
embolism, ARDS, cystic fibrosis
Renal and Fluid/Electrolyte 186-210 Acute kidney injury, chronic kidney disease, 10%
Disorders glomerulonephritis, electrolyte imbalances,
acid-base disorders
Endocrine Pathophysiology 211-235 Diabetes mellitus, thyroid disorders, adrenal 10%
insufficiency, Cushing syndrome, metabolic
syndrome
Neurologic and Other Systems 236-250 Stroke, Alzheimer disease, Parkinson 6%
disease, multiple sclerosis, meningitis,
shock, sepsis
Page 2
,Q1. A researcher is studying a novel signaling pathway where a ligand binds to a receptor tyrosine kinase,
leading to activation of Ras and subsequently the MAPK cascade. If a mutation causes constitutive activation
of Ras (GTP-bound form), which of the following cellular outcomes is most likely to occur, and what is the
direct consequence for cell cycle regulation?
A. Increased apoptosis due to sustained DNA damage signaling
B. Uncontrolled cell proliferation due to persistent activation of cyclin D1 transcription
C. Cell cycle arrest at G1/S checkpoint due to p53 activation
D. Differentiation into a non-proliferative state due to terminal signaling
Correct Answer: B. Uncontrolled cell proliferation due to persistent activation of cyclin D1 transcription
Rationale: Constitutive activation of Ras maintains the MAPK cascade, leading to continuous transcription of
cyclin D1, which drives G1 to S phase transition and uncontrolled proliferation. This is a classic oncogenic
mechanism. Apoptosis (A) is not directly triggered by Ras activation; p53 (C) is typically activated by DNA
damage, not Ras signaling. Differentiation (D) is not promoted by sustained MAPK signaling; rather, it often
blocks differentiation.
Why Wrong:
A - Constitutive Ras activation does not typically induce DNA damage signaling; it promotes proliferation,
not apoptosis.
C - p53 activation requires DNA damage or stress signals; Ras activation alone does not activate p53.
D - Sustained MAPK signaling generally inhibits differentiation and promotes proliferation.
Reference: Kumar, V., Abbas, A.K., & Aster, J.C. (2020). Robbins & Cotran Pathologic Basis of Disease, 10th Ed.,
Ch. 3 & 7.
Q2. In a patient with chronic venous insufficiency, stasis dermatitis and ulceration develop in the lower
extremities. Which sequence of pathophysiological events best explains the transition from venous
hypertension to tissue necrosis?
A. Increased hydrostatic pressure -> capillary rupture -> hemosiderin deposition -> fibroblast activation ->
fibrosis
B. Venous obstruction -> decreased arterial inflow -> ischemic necrosis -> neutrophil infiltration ->
liquefactive necrosis
C. Elevated venous pressure -> capillary leakage of fibrinogen -> pericapillary fibrin cuff -> impaired oxygen
diffusion -> cell death
D. Valvular incompetence -> retrograde flow -> arteriovenous shunting -> tissue hypoxia -> coagulative
necrosis
Correct Answer: C. Elevated venous pressure -> capillary leakage of fibrinogen -> pericapillary fibrin cuff ->
impaired oxygen diffusion -> cell death
Rationale: Chronic venous insufficiency leads to sustained venous hypertension, which causes leakage of
fibrinogen into the interstitium. Fibrinogen polymerizes into fibrin, forming a pericapillary cuff that impedes
oxygen diffusion, resulting in tissue hypoxia and eventual necrosis. Option A describes hemosiderin deposition and
fibrosis but not the direct cause of necrosis. Option B incorrectly suggests decreased arterial inflow; venous
insufficiency does not reduce arterial flow. Option D involves arteriovenous shunting, which is not a feature of
venous insufficiency.
Why Wrong:
A - Hemosiderin deposition and fibrosis are secondary changes but do not directly cause necrosis; the fibrin
cuff is critical.
B - Venous insufficiency does not decrease arterial inflow; ischemia is not the primary mechanism.
D - Arteriovenous shunting is not characteristic of venous insufficiency; the primary issue is impaired
diffusion.
Reference: Kumar, V., Abbas, A.K., & Aster, J.C. (2020). Robbins & Cotran Pathologic Basis of Disease, 10th Ed.,
Ch. 11.
Page 3
, Q3. A 45-year-old individual presents with recurrent thromboembolic events, including deep vein thrombosis
and pulmonary embolism. Laboratory findings reveal prolonged activated partial thromboplastin time
(aPTT) that does not correct with mixing studies. Which of the following is the most likely underlying
mechanism?
A. Deficiency of antithrombin III leading to uncontrolled thrombin activity
B. Mutation in factor V (Leiden) causing resistance to activated protein C
C. Presence of lupus anticoagulant, an autoantibody against phospholipid-bound proteins
D. Vitamin K deficiency resulting in decreased synthesis of factors II, VII, IX, X
Correct Answer: C. Presence of lupus anticoagulant, an autoantibody against phospholipid-bound proteins
Rationale: Lupus anticoagulant is an antiphospholipid antibody that paradoxically prolongs aPTT in vitro but promotes
thrombosis in vivo. The failure of mixing studies to correct indicates an inhibitor (autoantibody), not a factor deficiency.
Antithrombin III deficiency (A) would shorten aPTT or have no effect, not prolong it. Factor V Leiden (B) causes activated
protein C resistance but does not prolong aPTT. Vitamin K deficiency (D) would correct with mixing and is associated with
bleeding, not thrombosis.
Why Wrong:
A - Antithrombin III deficiency shortens aPTT or leaves it normal; it does not prolong aPTT.
B - Factor V Leiden does not affect aPTT; it is detected by functional assays for activated protein C resistance.
D - Vitamin K deficiency causes bleeding and corrects with mixing; it does not cause thrombosis.
Reference: Kumar, V., Abbas, A.K., & Aster, J.C. (2020). Robbins & Cotran Pathologic Basis of Disease, 10th Ed., Ch. 14.
Q4. In a patient with chronic kidney disease, secondary hyperparathyroidism develops due to phosphate
retention and decreased 1,25-dihydroxyvitamin D production. Which of the following best describes the
direct effect of elevated phosphate on parathyroid hormone (PTH) secretion?
A. Phosphate directly stimulates the calcium-sensing receptor on parathyroid chief cells
B. Hyperphosphatemia reduces serum ionized calcium, indirectly stimulating PTH secretion
C. Phosphate inhibits the enzymatic activity of 1-hydroxylase in the kidney
D. Phosphate binds to PTH receptors, causing receptor desensitization and increased secretion
Correct Answer: B. Hyperphosphatemia reduces serum ionized calcium, indirectly stimulating PTH
secretion
Rationale: Hyperphosphatemia in chronic kidney disease leads to a decrease in serum ionized calcium through
complexation and precipitation, which then stimulates PTH secretion via the calcium-sensing receptor. Phosphate
does not directly stimulate PTH; its effect is indirect through calcium lowering. Option A is incorrect because the
calcium-sensing receptor responds to calcium, not phosphate. Option C describes a mechanism that contributes to
vitamin D deficiency, not direct PTH stimulation. Option D is false; phosphate does not bind PTH receptors.
Why Wrong:
A - The calcium-sensing receptor is activated by calcium, not phosphate.
C - Inhibition of 1-hydroxylase reduces vitamin D, which indirectly affects PTH, but the direct effect of
phosphate is via calcium lowering.
D - Phosphate does not interact with PTH receptors; this is not a recognized mechanism.
Reference: Kumar, V., Abbas, A.K., & Aster, J.C. (2020). Robbins & Cotran Pathologic Basis of Disease, 10th Ed.,
Ch. 20.
Q5. A researcher is investigating a novel chemotherapeutic agent that targets the proteasome. In vitro, the
agent causes accumulation of ubiquitinated proteins and induces apoptosis in multiple myeloma cells. Which
of the following is the most direct mechanism by which proteasome inhibition leads to cell death?
A. Accumulation of misfolded proteins in the endoplasmic reticulum, triggering the unfolded protein response
B. Stabilization of the inhibitor of NF-B (IB), preventing NF-B nuclear translocation and pro-survival signaling
C. Direct activation of caspases through ubiquitin-mediated cleavage
D. Inhibition of DNA repair enzymes, leading to genomic instability and mitotic catastrophe
Page 4
Practice Test | 2026/2027 Edition | 250 Verified Questions
WGU D236 Pathophysiology Final Exam Review 2026-2027 QUESTIONS AND ANSWERS
ALREADY GRADED A+. 100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive review guide contains 250 verified questions and correct answers designed to
prepare students for the WGU D236 Pathophysiology Objective Assessment. Covering key concepts in
cellular injury, inflammation, immune disorders, neoplasia, and systemic pathophysiology, this test
bank reflects the latest 2026/2027 curriculum. Each question includes detailed rationales to reinforce
understanding and ensure exam readiness. Ideal for final exam review, this resource helps students
achieve a passing score with confidence.
Key Features:
Cellular Adaptation, Injury, and Death
Inflammation and Tissue Repair
Immune System Disorders and Hypersensitivities
Neoplasia and Cancer Biology
Cardiovascular and Respiratory Pathophysiology
Renal, Endocrine, and Neurologic Disorders
Updates for 2026:
- Updated to reflect 2026/2027 WGU D236 course objectives
- Revised rationales for clarity and accuracy
- Added new questions on COVID-19 and emerging pathogens
- Enhanced distractor explanations to address common misconceptions
- Aligned with latest NCLEX-style question formats
Abstract:
The WGU D236 Pathophysiology Objective Assessment Final Practice Test is a rigorous compilation of 250
multiple-choice questions that mirror the content and difficulty of the actual exam. This test bank systematically
covers fundamental pathophysiological concepts including cellular injury mechanisms, inflammatory responses,
immune dysfunctions, neoplastic processes, and organ system pathologies. Each question is accompanied by a
correct answer and a detailed rationale that explains the underlying pathophysiology, distinguishes correct from
incorrect options, and reinforces key principles. The content is organized by body system and disease process,
allowing for targeted review. This resource is essential for nursing and healthcare students seeking to master
pathophysiology and excel in their final objective assessment. By engaging with these questions, learners will
develop critical thinking skills and a deep understanding of disease mechanisms, preparing them for clinical
practice and licensure examinations.
Keywords:
WGU D236, Pathophysiology, Objective Assessment, Final Exam Review, Test Bank, 250 Questions, NCLEX Prep,
Nursing Pathophysiology
Answer Format:
Each question is followed by the correct answer in bold, then a detailed rationale explaining why the answer is
correct and why the other options are incorrect. Rationales include pathophysiological mechanisms, clinical
correlations, and key distinctions to enhance understanding and retention.
Compliance Checklist:
All questions aligned with WGU D236 2026/2027 course objectives
Page 1
, Answers verified by subject matter experts
Rationales provided for every question
Questions formatted in NCLEX-style multiple choice
Content reviewed for accuracy and currency
Suitable for self-assessment and exam preparation
Content Area Overview:
Content Area Questions Key Topics Weight
Cellular Biology and Injury 1-40 Cell adaptation, injury, death, atrophy, 16%
hypertrophy, hyperplasia, metaplasia,
dysplasia, apoptosis, necrosis
Inflammation and Healing 41-70 Acute inflammation, chronic inflammation, 12%
chemical mediators, wound healing, repair,
regeneration
Immune System Disorders 71-100 Hypersensitivity reactions, autoimmune 12%
diseases, immunodeficiency, transplant
rejection, HIV/AIDS
Neoplasia 101-130 Carcinogenesis, tumor classification, 12%
metastasis, oncogenes, tumor suppressor
genes, cancer staging
Cardiovascular Pathophysiology 131-160 Atherosclerosis, hypertension, heart failure, 12%
myocardial infarction, valvular disorders,
arrhythmias
Respiratory Pathophysiology 161-185 COPD, asthma, pneumonia, pulmonary 10%
embolism, ARDS, cystic fibrosis
Renal and Fluid/Electrolyte 186-210 Acute kidney injury, chronic kidney disease, 10%
Disorders glomerulonephritis, electrolyte imbalances,
acid-base disorders
Endocrine Pathophysiology 211-235 Diabetes mellitus, thyroid disorders, adrenal 10%
insufficiency, Cushing syndrome, metabolic
syndrome
Neurologic and Other Systems 236-250 Stroke, Alzheimer disease, Parkinson 6%
disease, multiple sclerosis, meningitis,
shock, sepsis
Page 2
,Q1. A researcher is studying a novel signaling pathway where a ligand binds to a receptor tyrosine kinase,
leading to activation of Ras and subsequently the MAPK cascade. If a mutation causes constitutive activation
of Ras (GTP-bound form), which of the following cellular outcomes is most likely to occur, and what is the
direct consequence for cell cycle regulation?
A. Increased apoptosis due to sustained DNA damage signaling
B. Uncontrolled cell proliferation due to persistent activation of cyclin D1 transcription
C. Cell cycle arrest at G1/S checkpoint due to p53 activation
D. Differentiation into a non-proliferative state due to terminal signaling
Correct Answer: B. Uncontrolled cell proliferation due to persistent activation of cyclin D1 transcription
Rationale: Constitutive activation of Ras maintains the MAPK cascade, leading to continuous transcription of
cyclin D1, which drives G1 to S phase transition and uncontrolled proliferation. This is a classic oncogenic
mechanism. Apoptosis (A) is not directly triggered by Ras activation; p53 (C) is typically activated by DNA
damage, not Ras signaling. Differentiation (D) is not promoted by sustained MAPK signaling; rather, it often
blocks differentiation.
Why Wrong:
A - Constitutive Ras activation does not typically induce DNA damage signaling; it promotes proliferation,
not apoptosis.
C - p53 activation requires DNA damage or stress signals; Ras activation alone does not activate p53.
D - Sustained MAPK signaling generally inhibits differentiation and promotes proliferation.
Reference: Kumar, V., Abbas, A.K., & Aster, J.C. (2020). Robbins & Cotran Pathologic Basis of Disease, 10th Ed.,
Ch. 3 & 7.
Q2. In a patient with chronic venous insufficiency, stasis dermatitis and ulceration develop in the lower
extremities. Which sequence of pathophysiological events best explains the transition from venous
hypertension to tissue necrosis?
A. Increased hydrostatic pressure -> capillary rupture -> hemosiderin deposition -> fibroblast activation ->
fibrosis
B. Venous obstruction -> decreased arterial inflow -> ischemic necrosis -> neutrophil infiltration ->
liquefactive necrosis
C. Elevated venous pressure -> capillary leakage of fibrinogen -> pericapillary fibrin cuff -> impaired oxygen
diffusion -> cell death
D. Valvular incompetence -> retrograde flow -> arteriovenous shunting -> tissue hypoxia -> coagulative
necrosis
Correct Answer: C. Elevated venous pressure -> capillary leakage of fibrinogen -> pericapillary fibrin cuff ->
impaired oxygen diffusion -> cell death
Rationale: Chronic venous insufficiency leads to sustained venous hypertension, which causes leakage of
fibrinogen into the interstitium. Fibrinogen polymerizes into fibrin, forming a pericapillary cuff that impedes
oxygen diffusion, resulting in tissue hypoxia and eventual necrosis. Option A describes hemosiderin deposition and
fibrosis but not the direct cause of necrosis. Option B incorrectly suggests decreased arterial inflow; venous
insufficiency does not reduce arterial flow. Option D involves arteriovenous shunting, which is not a feature of
venous insufficiency.
Why Wrong:
A - Hemosiderin deposition and fibrosis are secondary changes but do not directly cause necrosis; the fibrin
cuff is critical.
B - Venous insufficiency does not decrease arterial inflow; ischemia is not the primary mechanism.
D - Arteriovenous shunting is not characteristic of venous insufficiency; the primary issue is impaired
diffusion.
Reference: Kumar, V., Abbas, A.K., & Aster, J.C. (2020). Robbins & Cotran Pathologic Basis of Disease, 10th Ed.,
Ch. 11.
Page 3
, Q3. A 45-year-old individual presents with recurrent thromboembolic events, including deep vein thrombosis
and pulmonary embolism. Laboratory findings reveal prolonged activated partial thromboplastin time
(aPTT) that does not correct with mixing studies. Which of the following is the most likely underlying
mechanism?
A. Deficiency of antithrombin III leading to uncontrolled thrombin activity
B. Mutation in factor V (Leiden) causing resistance to activated protein C
C. Presence of lupus anticoagulant, an autoantibody against phospholipid-bound proteins
D. Vitamin K deficiency resulting in decreased synthesis of factors II, VII, IX, X
Correct Answer: C. Presence of lupus anticoagulant, an autoantibody against phospholipid-bound proteins
Rationale: Lupus anticoagulant is an antiphospholipid antibody that paradoxically prolongs aPTT in vitro but promotes
thrombosis in vivo. The failure of mixing studies to correct indicates an inhibitor (autoantibody), not a factor deficiency.
Antithrombin III deficiency (A) would shorten aPTT or have no effect, not prolong it. Factor V Leiden (B) causes activated
protein C resistance but does not prolong aPTT. Vitamin K deficiency (D) would correct with mixing and is associated with
bleeding, not thrombosis.
Why Wrong:
A - Antithrombin III deficiency shortens aPTT or leaves it normal; it does not prolong aPTT.
B - Factor V Leiden does not affect aPTT; it is detected by functional assays for activated protein C resistance.
D - Vitamin K deficiency causes bleeding and corrects with mixing; it does not cause thrombosis.
Reference: Kumar, V., Abbas, A.K., & Aster, J.C. (2020). Robbins & Cotran Pathologic Basis of Disease, 10th Ed., Ch. 14.
Q4. In a patient with chronic kidney disease, secondary hyperparathyroidism develops due to phosphate
retention and decreased 1,25-dihydroxyvitamin D production. Which of the following best describes the
direct effect of elevated phosphate on parathyroid hormone (PTH) secretion?
A. Phosphate directly stimulates the calcium-sensing receptor on parathyroid chief cells
B. Hyperphosphatemia reduces serum ionized calcium, indirectly stimulating PTH secretion
C. Phosphate inhibits the enzymatic activity of 1-hydroxylase in the kidney
D. Phosphate binds to PTH receptors, causing receptor desensitization and increased secretion
Correct Answer: B. Hyperphosphatemia reduces serum ionized calcium, indirectly stimulating PTH
secretion
Rationale: Hyperphosphatemia in chronic kidney disease leads to a decrease in serum ionized calcium through
complexation and precipitation, which then stimulates PTH secretion via the calcium-sensing receptor. Phosphate
does not directly stimulate PTH; its effect is indirect through calcium lowering. Option A is incorrect because the
calcium-sensing receptor responds to calcium, not phosphate. Option C describes a mechanism that contributes to
vitamin D deficiency, not direct PTH stimulation. Option D is false; phosphate does not bind PTH receptors.
Why Wrong:
A - The calcium-sensing receptor is activated by calcium, not phosphate.
C - Inhibition of 1-hydroxylase reduces vitamin D, which indirectly affects PTH, but the direct effect of
phosphate is via calcium lowering.
D - Phosphate does not interact with PTH receptors; this is not a recognized mechanism.
Reference: Kumar, V., Abbas, A.K., & Aster, J.C. (2020). Robbins & Cotran Pathologic Basis of Disease, 10th Ed.,
Ch. 20.
Q5. A researcher is investigating a novel chemotherapeutic agent that targets the proteasome. In vitro, the
agent causes accumulation of ubiquitinated proteins and induces apoptosis in multiple myeloma cells. Which
of the following is the most direct mechanism by which proteasome inhibition leads to cell death?
A. Accumulation of misfolded proteins in the endoplasmic reticulum, triggering the unfolded protein response
B. Stabilization of the inhibitor of NF-B (IB), preventing NF-B nuclear translocation and pro-survival signaling
C. Direct activation of caspases through ubiquitin-mediated cleavage
D. Inhibition of DNA repair enzymes, leading to genomic instability and mitotic catastrophe
Page 4
